Gloria Mittica
A.O.U. Città Della Salute E Della Scienza Di Torino, Ospedale Sant'Anna
Turin, Italy
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature.
Journal: Gynecologic oncology
Published: February 12, 2021
Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers.
Journal: Journal of ovarian research
Published: February 25, 2020
PIK3R1W624R Is an Actionable Mutation in High Grade Serous Ovarian Carcinoma.
Journal: Cells
Published: November 07, 2019
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 24, 2019
Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer.
Journal: Scientific reports
Published: July 10, 2019
Veliparib: a new therapeutic option in ovarian cancer?
Journal: Future oncology (London, England)
Published: May 11, 2019
Role of Mediterranean diet in preventing platinum based gastrointestinal toxicity in gynecolocological malignancies: A single Institution experience.
Journal: World journal of clinical oncology
Published: March 06, 2019
Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer.
Journal: International journal of molecular sciences
Published: February 28, 2019
TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers.
Journal: Journal of ovarian research
Published: August 25, 2018
Last Updated: 09/26/2026